A method for treating kaposi's sarcoma and blocking or...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/16 (2006.01)

Patent

CA 2126108

2126108 9312808 PCTABS00024 The present invention is directed to a method for arresting or inhibiting the growth of cells in Kaposi's Sarcoma lesions and a method for arresting or inhibiting the growth of the Kaposi's Sarcoma lesions, said methods comprising contacting the cells in the lesions with an effective amount of SP-PG, a naturally occuring sulfated polysaccharide-peptidoglycan produced by a specific species of the bacterium Arthrobacter, AT-25. The invention is also directed to blocking or inhibiting the activity of cellular vascular permeability factor(s), which comprises contacting vascular cells with an effective amount of SP-PG. In one embodiment, there is provided a method for blocking or inhibiting increased vascular permeability (and resulting edema) in diseases and disorders in which the increased vascular permeability contributes to the pathology, for example, in Kaposi's Sarcoma, tumorigenesis, inflammation, diabetic retinopathy, etc. Increased effectiveness is obtained when SP-PG is combined with cortisone or a cortisone derivative, such as hydrocortisone or tetrahydrocortisone.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

A method for treating kaposi's sarcoma and blocking or... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with A method for treating kaposi's sarcoma and blocking or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A method for treating kaposi's sarcoma and blocking or... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1921850

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.